AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potentially cheaper to make, easier to distribute and faster to scale-up than rivals.
The six countries of the Gulf Cooperation Council (GCC) have recorded more than 1 million cases of infection with COVID-19, according to a Reuters tally of data published by each government.
Germany's IDT Biologika plans to start a phase II trial of its experimental COVID-19 vaccine by the end of the year and hopes to be able to apply for approval in 2021, its Chief Executive said on Monday.
Merck & Co Inc has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in patients with severe or critical cases of COVID-19.
Indonesia reached a grim milestone on Monday in surpassing more than half a million coronavirus cases, as average new daily infections hit a record and hospitals in the country's most populated province edged closer to capacity.
AstraZeneca Plc said on Monday its vaccine for the novel coronavirus developed by Oxford University could be around 90% effective without any serious side effects.
Many of Germany's 16 federal states favour extending a partial shutdown meant to slow the spread of the COVID-19 pandemic and make family gatherings over Christmas possible, two state premiers said on Monday.
Britain medicines regulator said on Monday it would aim to make a decision on Pfizer and BioNTech's COVID-19 vaccine candidate "in the shortest time possible" after receiving additional data about the shot.
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, giving the world another important tool to halt the COVID-19 pandemic.
Russia reported a record 25,173 new coronavirus infections on Monday as the Kremlin said it was up to regional authorities to decide what measures needed to be imposed in their regions to curb its spread.
